RaQualia Pharma Inc
TSE:4579
RaQualia Pharma Inc
Cash from Financing Activities
RaQualia Pharma Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
RaQualia Pharma Inc
TSE:4579
|
Cash from Financing Activities
¥793.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
52%
|
CAGR 10-Years
10%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash from Financing Activities
-¥302.8B
|
CAGR 3-Years
29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash from Financing Activities
-¥123.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cash from Financing Activities
-¥60.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
8%
|
CAGR 10-Years
2%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash from Financing Activities
-¥139.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-20%
|
|
Astellas Pharma Inc
TSE:4503
|
Cash from Financing Activities
¥478.6B
|
CAGR 3-Years
53%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is RaQualia Pharma Inc's Cash from Financing Activities?
Cash from Financing Activities
793.5m
JPY
Based on the financial report for Dec 31, 2023, RaQualia Pharma Inc's Cash from Financing Activities amounts to 793.5m JPY.
What is RaQualia Pharma Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
10%